| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
5,666,359 | 5,245,806 | 5,487,092 | 4,438,601 | 4,777,624 |
| Cost of Revenue
|
-4,433,386 | -3,985,750 | -4,325,519 | -3,510,750 | -3,946,351 |
|
Gross Profit
|
1,232,973 | 1,260,056 | 1,161,573 | 927,851 | 831,273 |
| Selling, General and Administrative Expenses
|
-533,520 | -532,626 | -569,269 | -454,844 | -344,311 |
|
Research and Development Expenses
|
-17,739 | -17,445 | -19,497 | -19,134 | -16,456 |
|
Operating Income/Expenses
|
-551,259 | -550,071 | -588,766 | -473,978 | -360,767 |
|
Total Operating Profit/Loss
|
681,714 | 709,985 | 572,807 | 453,873 | 470,506 |
| Total Net Finance Income/Expense
|
22,820 | 31,561 | 12,187 | 45,724 | 9,402 |
| Irregular Income/Expenses
|
0 | 0 | 0 | 2,832 | 15,786 |
|
Other Income/Expense, Non-Operating
|
-10,351 | 2,737 | 85,310 | 33,267 | 30,308 |
|
Non-Operating Income/Expenses, Total
|
12,469 | 34,298 | 97,497 | 81,823 | 55,496 |
|
Pretax Income
|
694,183 | 744,283 | 670,304 | 535,696 | 526,002 |
|
Provision for Income Tax
|
-170,037 | -196,529 | -175,180 | -136,663 | -140,295 |
|
Net Income from Continuing Operations
|
524,146 | 547,754 | 495,124 | 399,033 | 385,707 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
524,146 | 547,754 | 495,124 | 399,033 | 385,707 |
|
Net Income after Non-Controlling/Minority Interests
|
524,146 | 547,754 | 495,124 | 399,033 | 385,707 |
|
Net Income Available to Common Stockholders
|
524,146 | 547,754 | 495,124 | 399,033 | 385,707 |
|
Diluted Net Income Available to Common Stockholders
|
524,146 | 547,754 | 495,124 | 399,033 | 385,707 |
| Basic EPS
|
7.18 | 7.50 | 6.78 | 5.46 | 5.28 |
| Diluted EPS
|
7.13 | 7.44 | 6.72 | 5.40 | 5.20 |
|
Basic Weighted Average Shares Outstanding
|
73,003.56 | 73,033.87 | 73,027.14 | 73,082.97 | 73,050.57 |
|
Diluted Weighted Average Shares Outstanding
|
73,515.32 | 73,622.85 | 73,679.17 | 73,895 | 74,174.42 |
|
EBIT
|
671,363 | 712,722 | 658,117 | 489,972 | 516,600 |
|
EBITDA
|
743,697 | 778,732 | 714,276 | 538,840 | 562,146 |
|
Normalized EBITDA
|
751,929 | 777,690 | 724,769 | 554,963 | 556,858 |
|
Normalized Income
|
530,361.61 | 546,987.14 | 502,874.72 | 411,042.81 | 381,829.42 |
|
Total Unusual Items
|
8,232 | -1,042 | 10,493 | 16,123 | -5,288 |
|
Total Unusual Items Excluding Goodwill
|
8,232 | -1,042 | 10,493 | 16,123 | -5,288 |
|
Tax Effect of Unusual Items
|
2,016.39 | -275.14 | 2,742.28 | 4,113.19 | -1,410.42 |
|
Tax Rate, Calculated
|
0.24 | 0.26 | 0.26 | 0.26 | 0.27 |
12/31/2022 - 12/31/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade